Proyectos
Research projects
Start of main content
Dyskeratosis congenita. New models, New molecular keys and New treatments
Enfermedades raras

Senior Researcher : María Luisa Cayuela Fuentes
Research Centre or Institution : Hospital Clínico Universitario Virgen de la Arrixaca. Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca. El Palmar, Murcia.
Abstract
Dyskeratosis congenita(DC) is a rare disease caused by mutations in the Telomerase complex or in the Shelfterin complex, as a result patients suffer telomeric shortening. The main cause of premature death is due to failure in hematopoiesis in 85% of cases or cancer in 10%. The variability and severity of the symptoms of the different mutations causing the disease is not well explained only by telomeric shortening, so we suspect that these components could be involved in other processes. Recently our group has shown that the genetic inhibition of the RNA component of telomerase (TR or TERC) in the zebrafish model causes a defect in myelopoiesis that is independent of telomeric length and telomerase activity, which explains the persistent neutropenia in children with DC. Our results suggest that TR acts as a long non-coding RNA (lncRNA) with regulatory functions in hematopoiesis beyond its function in telomeres. The objectives of the project are i) to identify the non-canonical functions of TERC in hematopoiesis and cancer and ii) establish therapeutic strategies.
Regarding the first of the objectives, our group has identified numerous proteins that interact with TERC, among them RNA polymerase II. Characterization of the interactors will reveal new targets for DC. We have also developed recently patented compounds, based on the knowledge generated about TERC, for the myelopoiesis activation in a context of TERC haploinsufficiency and for induced or atypical neutropenia.
Scientific Production |
|
---|---|
Magazine Articles | - |
Communications at national conferences | 3 |
Communications at international conferences | - |
-
Activities related
-
Projects related
-
News related
-
Publications related
Activities related
-
30
Oct
2023
Encuentro Red Nacional de Metástasis Cerebral (RENACER): Tres años de andadura conjunta Fundación Ramón Areces - salón de actos, Lunes, 30 de octubre de 2023, 10:45 horas
-
8
Apr
2024
Mesa Redonda Mundo de las prótesis, los nuevos materiales, sus complicaciones y su futuro Madrid , Lunes, 8 de abril 2024. 17.00 horas
-
23
Apr
2024
Jornada Situación actual de las Enfermedades Raras en España Madrid, Martes, 23 de abril de 2024, 10:00 horas
Projects related
- Disqueratosis congénita. Nuevos modelos, nuevas claves moleculares y nuevos tratamientos Senior Researcher : María Luisa Cayuela Fuentes
- Aplicación clínica de marcadores farmacogenéticos en el tratamiento del cáncer colorrectal. Establecimiento de pautas y recomendaciones terapéuticas Senior Researcher : Francisco Barros Angueira Research Centre or Institution : Hospital Clínico Universitario de Santiago de Compostela. Fundación Pública Galega de Medicina Xenómica.
- Farmacogenética en cáncer colorrectal Senior Researcher : Luis Andrés López Fernández Research Centre or Institution : Fundación para la Investigación Biomédica del Hospital Gregorio Marañón. Madrid
News related
Publications related
End of main content